Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
Keosys
iRECIST and Tumor Response to Immunotherapy with Infographic
iRecist and Tumor Response to Immunotherapy  When immunotherapy is used to..
Keosys
Keo-Tales: Looking Back and Looking Forward
Keosys is an imaging solutions provider supporting biopharmaceutical companies..
Keosys
Read Criteria and the Evaluation of Antitumor Responses With Immunotherapeutic Agents
This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..
Keosys
Imaging CROs Role in Clinical Research with Infographic
The use of imaging endpoints in clinical trials has steadily grown over the..
Keosys
Project Manager Stephanie Graf Joins the Keosys Team in the US
We are pleased to welcome Stephanie Graf to our Project Management team in the..
Keosys
Interview: Cancer Insight Leverages a Surgical Oncologist's Long Commitment to Service and Research
We recently spoke with George E. Peoples, M.D., founder and Chief Executive..
Keosys
Interview: Global Perspectives from a Global Powerhouse, Syneos Health
We recently spoke with Patrick Nealon, Executive Vice President and General..
Medical Imaging Data Synthesis using Generative Adversarial Networks
  Combining different modalities as done with PET/CT, clinical decision making..
Keosys
Interview: OncoBay Clinical Redefines What's Possible for CROs
We recently spoke with OncoBay Clinical executives Krystyna Kowalczyk, CEO, and..
Keosys
Interview: Orano Med and Leading in Nuclear Medicine
We recently spoke with Jason Hurt, MD, chief medical officer for Orano Med, a..

More Posts

New call-to-action